Neurotech Solutions Secures funding to Fuel Aggressive Growth of its ADHD screening and diagnosis business in China.

Neurotech solutions (NTS), a leading provider of software-based ADHD screening and diagnostic tests is expending its activity into the Chinese market. The company recently secured significant investment for sales growth in China from the Guangzhou-Israel Biomedical Fund (GIBF) . The transaction provides significant growth capital that will enable the company to grow into a $1B market opportunity, involving 211M School children. Read more…

[contact-form-7 id="4380" title="Popup exit heb"]

[contact-form-7 id="4379" title="Popup exit eng"]